It’s Deal Time in Biotech with Gilead Sciences $21B Acquisition of Immunomedics..COVID Testing boom!
Update-3 Coronavirus stocks are back led by testing boom and near term clinical news on CPOVID vaccine. Keep in mind it was a "triple witching" day.Here is a look-back to where we were with Coronavirus stocks on June 28. All pure play testing stocks are up big today on CDC and Gov buy-ins: CODX...
Large Cap Biopharmaceutical Performance and Metrics 9/4 2020…Update-2 COVID Dx!
Update-2 Choppy Day but Investors coming Back to Healthcare and Biopharma. IBB and XLV up a tad. XBI flat. Rotation out of high flying tech into healthcare and industrials. Large caps winners : AMGN and GILD then AZN,RHHBY,MRK looking for large caps that have Dx and Vx plays. Coronavirus...
Biotech Stocks are Lagging, Position your portfolio for a Q4 Rally with the XBI. Update-2 Downdraft!
Update-2 Downdraft surprises investors-momentum shift ! We have been talking about this for weeks, How much higher can the FAANG names go? The momentum is unprecedented. Bifurcated market. Well today the sell-off was in full swing with broad damage across the screen.We will need another day or...
Tough Time To Trade Biotech Stocks, Is the Momentum Market Easing?…Update-4 ABT Rapid Test!
We took profits on many longs and shorts in the coronavirus sector so I will need to look at new trades for Q4. Our small longs for now are ABT, AZT, GNMK, GILD, MRNA, MRK, OSUR and TDOC. However We are also long many large caps in addition to above: ABBV, BMY, JNJ, RHHBY. XBI has dropped a...
Biotech Momentum Stalled: Headwinds Remain for August.Update-3 Flattish week with healthcare lagging
August 15..Update -3...Momentum slows to a walk but XBI holds the $110 handle. XLV flat at $107 level, IBB down 0.86% to $133.30. Coronavirus stocks still within 10% of 52 week highs: HOLX,REGN; weak 2020 momentum: CEMI, INO. Vaccine stock leaders: NVAX, MRNA. Gov to purchase 100M doses vaccine...